Kumar R, Khan M, Panwar A, Vashist B, Rai S, Kumar A
Open Respir Med J. 2025; 18():e18743064340418.
PMID: 39839967
PMC: 11748061.
DOI: 10.2174/0118743064340418241021095046.
Sujie M, Kaiwen X, Hong X, Xiujin G
Front Med (Lausanne). 2024; 11:1359347.
PMID: 38966524
PMC: 11223526.
DOI: 10.3389/fmed.2024.1359347.
Mardi A, Abdolmohammadi-Vahid S, Sadeghi S, Jafarzadeh S, Abbaspour-Aghdam S, Hazrati A
Heliyon. 2024; 10(9):e30025.
PMID: 38737273
PMC: 11088266.
DOI: 10.1016/j.heliyon.2024.e30025.
Sveiven M, Serrano A, Rosenberg J, Conrad D, Hall D, ODonoghue A
Front Bioeng Biotechnol. 2024; 12:1363186.
PMID: 38544982
PMC: 10966768.
DOI: 10.3389/fbioe.2024.1363186.
Kim S, Lee S, Son A, Lee J, Kim H
Adv Healthc Mater. 2023; 12(30):e2301673.
PMID: 37505448
PMC: 11469264.
DOI: 10.1002/adhm.202301673.
Uncovering the cytotoxic effects of air pollution with multi-modal imaging of respiratory models.
Al-Rekabi Z, Dondi C, Faruqui N, Siddiqui N, Elowsson L, Rissler J
R Soc Open Sci. 2023; 10(4):221426.
PMID: 37063998
PMC: 10090883.
DOI: 10.1098/rsos.221426.
Increased airway resistance among exclusive waterpipe smokers detected using impulse oscillometry.
Chami H, Houjeij N, Makki M, Itani L, Tamim H, Al Mulla A
Ann Thorac Med. 2023; 18(1):23-30.
PMID: 36968332
PMC: 10034824.
DOI: 10.4103/atm.atm_165_22.
cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features.
Hasani Nourian Y, Salimian J, Ahmadi A, Salehi Z, Karimi M, Emamvirdizadeh A
Biochem Biophys Rep. 2023; 34:101438.
PMID: 36865738
PMC: 9971187.
DOI: 10.1016/j.bbrep.2023.101438.
Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease.
Kayongo A, Robertson N, Siddharthan T, Ntayi M, Ndawula J, Sande O
Front Immunol. 2023; 13:1085551.
PMID: 36741369
PMC: 9890194.
DOI: 10.3389/fimmu.2022.1085551.
Analysis of the Clinical Efficacy and Molecular Mechanism of Xuefu Zhuyu Decoction in the Treatment of COPD Based on Meta-Analysis and Network Pharmacology.
Hu Y, Lan Y, Ran Q, Gan Q, Huang W
Comput Math Methods Med. 2022; 2022:2615580.
PMID: 36479314
PMC: 9720234.
DOI: 10.1155/2022/2615580.
Plasma Extracellular Vesicle miRNA Profiles Distinguish Chronic Obstructive Pulmonary Disease Exacerbations and Disease Severity.
OFarrell H, Bowman R, Fong K, Yang I
Int J Chron Obstruct Pulmon Dis. 2022; 17:2821-2833.
PMID: 36381992
PMC: 9642085.
DOI: 10.2147/COPD.S379774.
Screening and identification of tissue-infiltrating immune cells and genes for patients with emphysema phenotype of COPD.
Wang D, Chen B, Bai S, Zhao L
Front Immunol. 2022; 13:967357.
PMID: 36248880
PMC: 9563378.
DOI: 10.3389/fimmu.2022.967357.
Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.
Dailah H
Molecules. 2022; 27(17).
PMID: 36080309
PMC: 9458015.
DOI: 10.3390/molecules27175542.
Exposure to second-hand smoke is an independent risk factor of small airway dysfunction in non-smokers with chronic cough: A retrospective case-control study.
Zhao B, Bai L, Wan R, Wang Y, Qin L, Xiao Q
Front Public Health. 2022; 10:912100.
PMID: 35937207
PMC: 9347364.
DOI: 10.3389/fpubh.2022.912100.
Impaired Alveolar Re-Epithelialization in Pulmonary Emphysema.
Lin C, Bahmed K, Kosmider B
Cells. 2022; 11(13).
PMID: 35805139
PMC: 9265977.
DOI: 10.3390/cells11132055.
Lung tissue shows divergent gene expression between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Ghosh A, Hobbs B, Yun J, Saferali A, Moll M, Xu Z
Respir Res. 2022; 23(1):97.
PMID: 35449067
PMC: 9026726.
DOI: 10.1186/s12931-022-02013-w.
Dysregulated Cell Signaling in Pulmonary Emphysema.
Lin C, Bahmed K, Kosmider B
Front Med (Lausanne). 2022; 8:762878.
PMID: 35047522
PMC: 8762198.
DOI: 10.3389/fmed.2021.762878.
Emphysema-Predominant COPD Had a Greater 5-Year Mortality and a Worse Annual Decline in Lung Function Than Airway Obstruction-Predominant COPD or Asthma at Initial Same Degree of Airflow Obstruction.
Lin C, Huang H, Chung F, Lo C, Huang Y, Wang T
Medicina (Kaunas). 2021; 57(11).
PMID: 34833478
PMC: 8622286.
DOI: 10.3390/medicina57111261.
From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease.
Wang H, Cheng S
Biomedicines. 2021; 9(11).
PMID: 34829866
PMC: 8615492.
DOI: 10.3390/biomedicines9111638.
Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease.
de Oliveira Rodrigues S, da Cunha C, Soares G, Silva P, Silva A, Goncalves-de-Albuquerque C
Pharmaceuticals (Basel). 2021; 14(10).
PMID: 34681202
PMC: 8539950.
DOI: 10.3390/ph14100979.
